| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 138.679 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 117.218 | 77 |
| GSM780709 | Untreated after 4 days (C3_1) | 116.992 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 136.384 | 79 |
| GSM780720 | Untreated after 4 days (C2_2) | 124.209 | 78 |
| GSM780721 | Untreated after 4 days (C3_2) | 123.754 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 103.352 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 136.667 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 134.036 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 125.842 | 78 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 142.105 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 128.122 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 181.037 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 116.549 | 77 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 177.675 | 82 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 182.408 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 128.153 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 158.161 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 147.548 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 144.71 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 151.837 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 152.199 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 130.369 | 79 |